Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+45.6%
5Y CAGR+66.6%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+45.6%/yr
vs +38.1%/yr prior
5Y CAGR
+66.6%/yr
Recent deceleration
Acceleration
+7.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
12.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $119.66M | +14.4% |
| 2024 | $104.55M | +25.2% |
| 2023 | $83.53M | +115.3% |
| 2022 | $38.79M | +56.7% |
| 2021 | $24.76M | +165.7% |
| 2020 | $9.32M | -61.4% |
| 2019 | $24.12M | +125.9% |
| 2018 | $10.68M | +19.9% |
| 2017 | $8.90M | - |